PCM
RBOT

Pointe Capital Management’s Vicarious Surgical RBOT Stock Holding History

Pointe Capital Management’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33
Closed -$2.27K – 335
2023
Q1 		$2.27K Buy
+33
New +$2.57K ﹤0.01% 377

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pointe Capital Management's RBOT Position: Q2 2023 in Review

Pointe Capital Management sold out of Vicarious Surgical (RBOT) in Q2 2023, closing a stake of 33 shares — an estimated $2.27K sold.

Pointe Capital Management first reported a position in RBOT in Q1 2023 and held it in 1 quarter. The position peaked at $2.27K in Q1 2023. 74 funds tracked by Wall St. Rank hold RBOT as of Q2 2023.

  • Pointe Capital Management reported no remaining Vicarious Surgical position as of Q2 2023 after selling out during the quarter.
  • Pointe Capital Management sold 33 Vicarious Surgical shares in Q2 2023, an estimated $2.27K.
  • Pointe Capital Management first reported a position in Vicarious Surgical in Q1 2023 and held it in 1 quarter.
  • Pointe Capital Management's Vicarious Surgical position peaked at $2.27K in Q1 2023.
  • 74 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2023.

Based on Pointe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.